1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Opsoclonus-Myoclonus Syndrome: new trials by email Literature Review of Opsoclonus-Myoclonus Syndrome trials Research Report on Opsoclonus-Myoclonus Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Rituximab in Pediatric OMS Patients. rituximab - Opsoclonus-myoclonus Syndrome, Opsoclonus | Phase 1 / Phase 2 | Completed | National Pediatric Neuroinflammation Organization, Inc. | 25 | 2005-06-01 | 2011-05-10 |
Ataxia (1) · Myoclonus (1) · Ocular Motility Disorders (1)
Central Nervous System Diseases (1) · Cranial Nerve Diseases (1) · Dyskinesias (1) · Eye Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Paraneoplastic Syndromes (1) · Paraneoplastic Syndromes, Nervous System (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Rituximab (1)
National Pediatric Neuroinflammation Organization, Inc. (1)
United States (1)
Michael R Pranzatelli, M.D. (1)